ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,985.38
      0.02%
      US Tech 100
      20,509.20
      0.09%
      Dow Jones
      43,958.19
      0.11%
      Brent Oil
      72.425
      0.78%
      Bitcoin
      91,197.46
      0.70%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Mesoblast Limited (MESO) Quote

      Mesoblast Limited

      Mesoblast Limited (MESO)

      NASDAQ
      11.705
      1.76
      (17.64%)
      Closed November 13 4:00PM
      Delayed by 15 minutes
      11.705
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      11.705
      Bid
      10.07
      Ask
      12.50
      Volume
      10
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      1.336B
      Previous Close
      11.705
      Open
      -
      Last Trade
      10
      @
      11.72
      Last Trade Time
      05:18:52
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      114,178,411
      Dividend Yield
      -
      PE Ratio
      -2.32
      Earnings Per Share (EPS)
      -0.77
      Revenue
      9.25M
      Net Profit
      -87.96M

      About Mesoblast Limited

      Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-... Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.mesoblast.com
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      -
      Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MESO. The last closing price for Mesoblast was $11.71. Over the last year, Mesoblast shares have traded in a share price range of $ 0.00 to $ 0.00.

      Mesoblast currently has 114,178,411 shares outstanding. The market capitalization of Mesoblast is $1.34 billion. Mesoblast has a price to earnings ratio (PE ratio) of -2.32.

      Ask ADVFN Intelligence (AI)

      Mesoblast (MESO) Options Flow Summary

      MESO Options Flow

      Overall Flow

      Bullish

      Net Premium

      138k

      Calls / Puts

      100.00%

      Buys / Sells

      150.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      MESO Latest News

      More News

      Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024

      NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its...

      October 30 2024
      GlobeNewswire Inc.

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      October 09 2024
      Edgar (US Regulatory)

      Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch

      NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered...

      September 29 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 29 2024
      Edgar (US Regulatory)

      Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024

      NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an operational...

      August 28 2024
      GlobeNewswire Inc.

      Mesoblast Financial Results and Corporate Update Webcast

      NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss...

      August 27 2024
      GlobeNewswire Inc.

      Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2024

      NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its...

      July 30 2024
      GlobeNewswire Inc.

      FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

      NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States...

      July 23 2024
      GlobeNewswire Inc.

      Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

      NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the...

      July 21 2024
      GlobeNewswire Inc.

      Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

      NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it has resubmitted...

      July 08 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LGHLWLion Group Holding Ltd
      $ 0.03
      (279.75%)
      		83
      ELABElevai Labs Inc
      $ 0.044
      (78.14%)
      		288.68M
      BCALCalifornia BanCorp
      $ 23.01
      (33.08%)
      		100
      FTFTFuture FinTech Group Inc
      $ 0.5079
      (31.41%)
      		4.91k
      QUBTQuantum Computing Inc
      $ 3.48
      (30.83%)
      		17.67M
      HROWHarrow Inc
      $ 37.50
      (-27.61%)
      		34.89k
      DBGIDigital Brands Group Inc
      $ 0.1355
      (-25.06%)
      		2.22M
      ELVNEnliven Therapeutics Inc
      $ 20.00
      (-22.48%)
      		90
      SPFISouth Plains Financial Inc
      $ 31.00
      (-20.90%)
      		1
      BHRBBurke and Herbert Financial Services Corporation
      $ 55.10
      (-20.62%)
      		90
      ELABElevai Labs Inc
      $ 0.044
      (78.14%)
      		288.68M
      SVMHSRIVARU Holding Ltd
      $ 0.0308
      (27.27%)
      		48.05M
      XTIAXTI Aerospace Inc
      $ 0.0735
      (28.50%)
      		26.43M
      QUBTQuantum Computing Inc
      $ 3.48
      (30.83%)
      		17.67M
      MVSTMicrovast Holdings Inc
      $ 0.9276
      (16.66%)
      		9.57M

      MESO Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      MESO under $10
      👍️0
      Monksdream Monksdream 2 months ago
      MESO under $7
      👍️0
      Monksdream Monksdream 4 months ago
      MESO under $8
      👍️0
      Monksdream Monksdream 6 months ago
      MESO like the chart
      👍️0
      gail gail 7 months ago
      and she dipped, watching for re entry maybe.
      👍️0
      gail gail 7 months ago
      boom, off she runs even more. wow!
      👍️0
      gail gail 7 months ago
      about to bust the HOD here.
      👍️0
      gail gail 7 months ago
      and there she goes. off to the races.
      👍️0
      gail gail 7 months ago
      quiet board, loving this run so far!
      👍️0
      gail gail 7 months ago
      here we gooooo!!! weeee!!!
      👍️0
      gail gail 7 months ago
      grabbed some here.
      👍️0
      Awl416 Awl416 7 months ago
      ….
      👍️0
      Awl416 Awl416 8 months ago
      Continues…..
      👍️0
      stressfreeliving stressfreeliving 8 months ago
      Picked up shares. Look forward to where this goes.

      $MESO
      👍️0
      Invest-in-America Invest-in-America 8 months ago
      MESO: And the hands-down WINNER of the day is MESO!!!!
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      MESO out
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      MESO shake over and ready to go
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      MESO...MONSTER COMING IN HERE
      👍️0
      Monksdream Monksdream 9 months ago
      MESO under $2
      👍️0
      powerbattles powerbattles 9 months ago
      I can't believe stock doesn't move on this great news.
      👍️0
      Awl416 Awl416 10 months ago
      United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
      👍️0
      Monksdream Monksdream 10 months ago
      MESO new 52 week low
      👍️0
      TheFinalCD TheFinalCD 11 months ago
      where have I heard that before?
      👍️0
      Monksdream Monksdream 11 months ago
      A rising tide lifts all boats, including the leaking ones
      👎️ 1
      TheFinalCD TheFinalCD 11 months ago
      https://www.mesoblast.com/
      👍️0
      Monksdream Monksdream 1 year ago
      MESO under $2
      👍️0
      abrasivegritin abrasivegritin 2 years ago
      I think COmpany should have a look at new markets specially in Russia Ukraine , since all the things there are been destroyed and revaming them need Sand blasting and Shot blasting service . with all kind of Abrasive like Silicon Carbide and Aluminum Oxide Grit
      👍️0
      basssque basssque 2 years ago
      5 day chart looks good, I'm in!
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      How you doing
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      Let's go Brando
      👍️0
      REAGAN REAGAN 3 years ago
      All of these RegMed stocks are scams bullshit 2000’s era stocks that never came to fruition.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      No
      👍️0
      midastouch017 midastouch017 4 years ago
      Wasn't PSTI not $13 not too long ago?
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Wasn't this $17 not too long ago.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      What's the frequency Dan
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Lol
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Yes
      👍️0
      midastouch017 midastouch017 4 years ago
      Lol, are you absolutely sure?
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      This one's going down under
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      See post #232 FangFang sold over 2 million shares yesterday.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      WOW!
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Holy Moly
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Halted until Friday
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Plausible deniability
      👍️0
      trickledownfacists trickledownfacists 4 years ago
      Nice work!
      👍️0
      Glider549 Glider549 4 years ago
      https://biopharmcatalyst.us13.list-manage.com/track/click?u=ce642b003b32103d28995373d&id=26ab819ef9&e=d1924831d6
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Down over 50%
      👍️0
      creationtruth creationtruth 4 years ago
      News out tomorrow for CYDY Tomorrow 4ET. Hopefully we’ll get treated better than MESO.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      This is Getting ugly
      👍️0
      emit emit 4 years ago
      I let go 1/3 my psti this morning.

      Sold all this to.


      e
      👍️0

      Your Recent History

      NASDAQ
      MESO
      Mesoblast
      BIT
      TYA
      Toscana Aeroporti
      AQSE
      KNDR
      Kondor AI
      Delayed Upgrade Clock